Radezolid (INN, codenamed RX-1741) is a novel oxazolidinone antibiotic being developed by Melinta Therapeutics, Inc. for the treatment of bacterial acne.
via PubMed
{{Drugbox | IUPAC_name = N-{[(5S)-3-(2-fluoro-4′-{[(1H-1,2,3-triazol-5-ylmethyl)amino]methyl}biphenyl-4-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide | image = Radezolid.svg | image_class = skin-invert-image | alt = Skeletal formula of radezolid
| tradename = | legal_status = Investigational | routes_of_administration = Intravenous infusion, oral
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).